Pharmaceutical

Certara sees highest patent filings and grants during June in Q2 2024

Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.

Jul 22, 2024 - 04:00
Certara sees highest patent filings and grants during June in Q2 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.
Read the original article

Tags:

Previous Article

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Next Article

iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Hipra’s Covid-19 booster gets EMA nod and enters an uncertain landscape

Hipra’s Covid-19 booster gets EMA nod and enters an unc...

Mar 31, 2023

FDA grants breakthrough therapy status for Nuvalent’s NVL-655

FDA grants breakthrough therapy status for Nuvalent’s N...

May 19, 2024

LAPIX receives US patent for LPX-TI641 to treat autoimmune diseases

LAPIX receives US patent for LPX-TI641 to treat autoimm...

May 18, 2023